 | • レポートコード：QFJ1-4537 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、筋骨格系障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（関節リウマチ、変形性関節症、骨粗鬆症、その他）、用途別市場規模（病院・クリニック、学術・研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・筋骨格系障害の市場動向 ・企業の競争状況、市場シェア ・筋骨格系障害の種類別市場規模と予測2016-2027（関節リウマチ、変形性関節症、骨粗鬆症、その他） ・筋骨格系障害の用途別市場規模と予測2016-2027（病院・クリニック、学術・研究所） ・筋骨格系障害の北米市場規模2016-2027（アメリカ、カナダ） ・筋骨格系障害の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋骨格系障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋骨格系障害の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋骨格系障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB Science、AbGenomics International, Inc.、Alder BioPharmaceuticals,Inc.、Amgen Inc.、Lexicon Pharmaceuticals, Inc.、LG Chem、OrthoTrophix, Inc.、Tarsa Therapeutics, Inc.、PhytoHealth Corporation、Eisai Co., Ltd、Astellas Pharma Inc.、AstraZeneca、Baxter、GlaxoSmithKline PLC） ・結論 |
Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.
Market Analysis and Insights: Global Musculoskeletal System Disorder Market
The global Musculoskeletal System Disorder market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Musculoskeletal System Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Musculoskeletal System Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Musculoskeletal System Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Musculoskeletal System Disorder market.
Global Musculoskeletal System Disorder Scope and Market Size
Musculoskeletal System Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Musculoskeletal System Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Others
Segment by Application
Hospitals & Clinics
Academic & Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AB Science
AbGenomics International, Inc.
Alder BioPharmaceuticals,Inc.
Amgen Inc.
Lexicon Pharmaceuticals, Inc.
LG Chem
OrthoTrophix, Inc.
Tarsa Therapeutics, Inc.
PhytoHealth Corporation
Eisai Co., Ltd
Astellas Pharma Inc.
AstraZeneca
Baxter
GlaxoSmithKline PLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal System Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rheumatoid Arthritis
1.2.3 Osteoarthritis
1.2.4 Osteoporosis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Musculoskeletal System Disorder Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal System Disorder Market Perspective (2016-2027)
2.2 Musculoskeletal System Disorder Growth Trends by Regions
2.2.1 Musculoskeletal System Disorder Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Musculoskeletal System Disorder Historic Market Share by Regions (2016-2021)
2.2.3 Musculoskeletal System Disorder Forecasted Market Size by Regions (2022-2027)
2.3 Musculoskeletal System Disorder Industry Dynamic
2.3.1 Musculoskeletal System Disorder Market Trends
2.3.2 Musculoskeletal System Disorder Market Drivers
2.3.3 Musculoskeletal System Disorder Market Challenges
2.3.4 Musculoskeletal System Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal System Disorder Players by Revenue
3.1.1 Global Top Musculoskeletal System Disorder Players by Revenue (2016-2021)
3.1.2 Global Musculoskeletal System Disorder Revenue Market Share by Players (2016-2021)
3.2 Global Musculoskeletal System Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal System Disorder Revenue
3.4 Global Musculoskeletal System Disorder Market Concentration Ratio
3.4.1 Global Musculoskeletal System Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Revenue in 2020
3.5 Musculoskeletal System Disorder Key Players Head office and Area Served
3.6 Key Players Musculoskeletal System Disorder Product Solution and Service
3.7 Date of Enter into Musculoskeletal System Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal System Disorder Breakdown Data by Type
4.1 Global Musculoskeletal System Disorder Historic Market Size by Type (2016-2021)
4.2 Global Musculoskeletal System Disorder Forecasted Market Size by Type (2022-2027)
5 Musculoskeletal System Disorder Breakdown Data by Application
5.1 Global Musculoskeletal System Disorder Historic Market Size by Application (2016-2021)
5.2 Global Musculoskeletal System Disorder Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Musculoskeletal System Disorder Market Size (2016-2027)
6.2 North America Musculoskeletal System Disorder Market Size by Type
6.2.1 North America Musculoskeletal System Disorder Market Size by Type (2016-2021)
6.2.2 North America Musculoskeletal System Disorder Market Size by Type (2022-2027)
6.2.3 North America Musculoskeletal System Disorder Market Size by Type (2016-2027)
6.3 North America Musculoskeletal System Disorder Market Size by Application
6.3.1 North America Musculoskeletal System Disorder Market Size by Application (2016-2021)
6.3.2 North America Musculoskeletal System Disorder Market Size by Application (2022-2027)
6.3.3 North America Musculoskeletal System Disorder Market Size by Application (2016-2027)
6.4 North America Musculoskeletal System Disorder Market Size by Country
6.4.1 North America Musculoskeletal System Disorder Market Size by Country (2016-2021)
6.4.2 North America Musculoskeletal System Disorder Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Musculoskeletal System Disorder Market Size (2016-2027)
7.2 Europe Musculoskeletal System Disorder Market Size by Type
7.2.1 Europe Musculoskeletal System Disorder Market Size by Type (2016-2021)
7.2.2 Europe Musculoskeletal System Disorder Market Size by Type (2022-2027)
7.2.3 Europe Musculoskeletal System Disorder Market Size by Type (2016-2027)
7.3 Europe Musculoskeletal System Disorder Market Size by Application
7.3.1 Europe Musculoskeletal System Disorder Market Size by Application (2016-2021)
7.3.2 Europe Musculoskeletal System Disorder Market Size by Application (2022-2027)
7.3.3 Europe Musculoskeletal System Disorder Market Size by Application (2016-2027)
7.4 Europe Musculoskeletal System Disorder Market Size by Country
7.4.1 Europe Musculoskeletal System Disorder Market Size by Country (2016-2021)
7.4.2 Europe Musculoskeletal System Disorder Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal System Disorder Market Size (2016-2027)
8.2 Asia-Pacific Musculoskeletal System Disorder Market Size by Type
8.2.1 Asia-Pacific Musculoskeletal System Disorder Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Musculoskeletal System Disorder Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Type (2016-2027)
8.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Application
8.3.1 Asia-Pacific Musculoskeletal System Disorder Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Musculoskeletal System Disorder Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Application (2016-2027)
8.4 Asia-Pacific Musculoskeletal System Disorder Market Size by Region
8.4.1 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Musculoskeletal System Disorder Market Size (2016-2027)
9.2 Latin America Musculoskeletal System Disorder Market Size by Type
9.2.1 Latin America Musculoskeletal System Disorder Market Size by Type (2016-2021)
9.2.2 Latin America Musculoskeletal System Disorder Market Size by Type (2022-2027)
9.2.3 Latin America Musculoskeletal System Disorder Market Size by Type (2016-2027)
9.3 Latin America Musculoskeletal System Disorder Market Size by Application
9.3.1 Latin America Musculoskeletal System Disorder Market Size by Application (2016-2021)
9.3.2 Latin America Musculoskeletal System Disorder Market Size by Application (2022-2027)
9.3.3 Latin America Musculoskeletal System Disorder Market Size by Application (2016-2027)
9.4 Latin America Musculoskeletal System Disorder Market Size by Country
9.4.1 Latin America Musculoskeletal System Disorder Market Size by Country (2016-2021)
9.4.2 Latin America Musculoskeletal System Disorder Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal System Disorder Market Size (2016-2027)
10.2 Middle East & Africa Musculoskeletal System Disorder Market Size by Type
10.2.1 Middle East & Africa Musculoskeletal System Disorder Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Musculoskeletal System Disorder Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Type (2016-2027)
10.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Application
10.3.1 Middle East & Africa Musculoskeletal System Disorder Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Musculoskeletal System Disorder Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Application (2016-2027)
10.4 Middle East & Africa Musculoskeletal System Disorder Market Size by Country
10.4.1 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Details
11.1.2 AB Science Business Overview
11.1.3 AB Science Musculoskeletal System Disorder Introduction
11.1.4 AB Science Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.1.5 AB Science Recent Development
11.2 AbGenomics International, Inc.
11.2.1 AbGenomics International, Inc. Company Details
11.2.2 AbGenomics International, Inc. Business Overview
11.2.3 AbGenomics International, Inc. Musculoskeletal System Disorder Introduction
11.2.4 AbGenomics International, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.2.5 AbGenomics International, Inc. Recent Development
11.3 Alder BioPharmaceuticals,Inc.
11.3.1 Alder BioPharmaceuticals,Inc. Company Details
11.3.2 Alder BioPharmaceuticals,Inc. Business Overview
11.3.3 Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Introduction
11.3.4 Alder BioPharmaceuticals,Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.3.5 Alder BioPharmaceuticals,Inc. Recent Development
11.4 Amgen Inc.
11.4.1 Amgen Inc. Company Details
11.4.2 Amgen Inc. Business Overview
11.4.3 Amgen Inc. Musculoskeletal System Disorder Introduction
11.4.4 Amgen Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.4.5 Amgen Inc. Recent Development
11.5 Lexicon Pharmaceuticals, Inc.
11.5.1 Lexicon Pharmaceuticals, Inc. Company Details
11.5.2 Lexicon Pharmaceuticals, Inc. Business Overview
11.5.3 Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Introduction
11.5.4 Lexicon Pharmaceuticals, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.5.5 Lexicon Pharmaceuticals, Inc. Recent Development
11.6 LG Chem
11.6.1 LG Chem Company Details
11.6.2 LG Chem Business Overview
11.6.3 LG Chem Musculoskeletal System Disorder Introduction
11.6.4 LG Chem Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.6.5 LG Chem Recent Development
11.7 OrthoTrophix, Inc.
11.7.1 OrthoTrophix, Inc. Company Details
11.7.2 OrthoTrophix, Inc. Business Overview
11.7.3 OrthoTrophix, Inc. Musculoskeletal System Disorder Introduction
11.7.4 OrthoTrophix, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.7.5 OrthoTrophix, Inc. Recent Development
11.8 Tarsa Therapeutics, Inc.
11.8.1 Tarsa Therapeutics, Inc. Company Details
11.8.2 Tarsa Therapeutics, Inc. Business Overview
11.8.3 Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Introduction
11.8.4 Tarsa Therapeutics, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.8.5 Tarsa Therapeutics, Inc. Recent Development
11.9 PhytoHealth Corporation
11.9.1 PhytoHealth Corporation Company Details
11.9.2 PhytoHealth Corporation Business Overview
11.9.3 PhytoHealth Corporation Musculoskeletal System Disorder Introduction
11.9.4 PhytoHealth Corporation Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.9.5 PhytoHealth Corporation Recent Development
11.10 Eisai Co., Ltd
11.10.1 Eisai Co., Ltd Company Details
11.10.2 Eisai Co., Ltd Business Overview
11.10.3 Eisai Co., Ltd Musculoskeletal System Disorder Introduction
11.10.4 Eisai Co., Ltd Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.10.5 Eisai Co., Ltd Recent Development
11.11 Astellas Pharma Inc.
11.11.1 Astellas Pharma Inc. Company Details
11.11.2 Astellas Pharma Inc. Business Overview
11.11.3 Astellas Pharma Inc. Musculoskeletal System Disorder Introduction
11.11.4 Astellas Pharma Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.11.5 Astellas Pharma Inc. Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Musculoskeletal System Disorder Introduction
11.12.4 AstraZeneca Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.12.5 AstraZeneca Recent Development
11.13 Baxter
11.13.1 Baxter Company Details
11.13.2 Baxter Business Overview
11.13.3 Baxter Musculoskeletal System Disorder Introduction
11.13.4 Baxter Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.13.5 Baxter Recent Development
11.14 GlaxoSmithKline PLC
11.14.1 GlaxoSmithKline PLC Company Details
11.14.2 GlaxoSmithKline PLC Business Overview
11.14.3 GlaxoSmithKline PLC Musculoskeletal System Disorder Introduction
11.14.4 GlaxoSmithKline PLC Revenue in Musculoskeletal System Disorder Business (2016-2021)
11.14.5 GlaxoSmithKline PLC Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Musculoskeletal System Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rheumatoid Arthritis
Table 3. Key Players of Osteoarthritis
Table 4. Key Players of Osteoporosis
Table 5. Key Players of Others
Table 6. Global Musculoskeletal System Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Musculoskeletal System Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Musculoskeletal System Disorder Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Musculoskeletal System Disorder Market Share by Regions (2016-2021)
Table 10. Global Musculoskeletal System Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Musculoskeletal System Disorder Market Share by Regions (2022-2027)
Table 12. Musculoskeletal System Disorder Market Trends
Table 13. Musculoskeletal System Disorder Market Drivers
Table 14. Musculoskeletal System Disorder Market Challenges
Table 15. Musculoskeletal System Disorder Market Restraints
Table 16. Global Musculoskeletal System Disorder Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Musculoskeletal System Disorder Market Share by Players (2016-2021)
Table 18. Global Top Musculoskeletal System Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal System Disorder as of 2020)
Table 19. Ranking of Global Top Musculoskeletal System Disorder Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Musculoskeletal System Disorder Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Musculoskeletal System Disorder Product Solution and Service
Table 23. Date of Enter into Musculoskeletal System Disorder Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Musculoskeletal System Disorder Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Musculoskeletal System Disorder Revenue Market Share by Type (2016-2021)
Table 27. Global Musculoskeletal System Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Musculoskeletal System Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Musculoskeletal System Disorder Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Musculoskeletal System Disorder Revenue Market Share by Application (2016-2021)
Table 31. Global Musculoskeletal System Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Musculoskeletal System Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Musculoskeletal System Disorder Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Musculoskeletal System Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Musculoskeletal System Disorder Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Musculoskeletal System Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Musculoskeletal System Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Musculoskeletal System Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Musculoskeletal System Disorder Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Musculoskeletal System Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Musculoskeletal System Disorder Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Musculoskeletal System Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Musculoskeletal System Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Musculoskeletal System Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Musculoskeletal System Disorder Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Musculoskeletal System Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Musculoskeletal System Disorder Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Musculoskeletal System Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Musculoskeletal System Disorder Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Musculoskeletal System Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Musculoskeletal System Disorder Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Musculoskeletal System Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Musculoskeletal System Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Musculoskeletal System Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Musculoskeletal System Disorder Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Musculoskeletal System Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Musculoskeletal System Disorder Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Musculoskeletal System Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 63. AB Science Company Details
Table 64. AB Science Business Overview
Table 65. AB Science Musculoskeletal System Disorder Product
Table 66. AB Science Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 67. AB Science Recent Development
Table 68. AbGenomics International, Inc. Company Details
Table 69. AbGenomics International, Inc. Business Overview
Table 70. AbGenomics International, Inc. Musculoskeletal System Disorder Product
Table 71. AbGenomics International, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 72. AbGenomics International, Inc. Recent Development
Table 73. Alder BioPharmaceuticals,Inc. Company Details
Table 74. Alder BioPharmaceuticals,Inc. Business Overview
Table 75. Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Product
Table 76. Alder BioPharmaceuticals,Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 77. Alder BioPharmaceuticals,Inc. Recent Development
Table 78. Amgen Inc. Company Details
Table 79. Amgen Inc. Business Overview
Table 80. Amgen Inc. Musculoskeletal System Disorder Product
Table 81. Amgen Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 82. Amgen Inc. Recent Development
Table 83. Lexicon Pharmaceuticals, Inc. Company Details
Table 84. Lexicon Pharmaceuticals, Inc. Business Overview
Table 85. Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Product
Table 86. Lexicon Pharmaceuticals, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 87. Lexicon Pharmaceuticals, Inc. Recent Development
Table 88. LG Chem Company Details
Table 89. LG Chem Business Overview
Table 90. LG Chem Musculoskeletal System Disorder Product
Table 91. LG Chem Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 92. LG Chem Recent Development
Table 93. OrthoTrophix, Inc. Company Details
Table 94. OrthoTrophix, Inc. Business Overview
Table 95. OrthoTrophix, Inc. Musculoskeletal System Disorder Product
Table 96. OrthoTrophix, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 97. OrthoTrophix, Inc. Recent Development
Table 98. Tarsa Therapeutics, Inc. Company Details
Table 99. Tarsa Therapeutics, Inc. Business Overview
Table 100. Tarsa Therapeutics, Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 101. Tarsa Therapeutics, Inc. Recent Development
Table 102. PhytoHealth Corporation Company Details
Table 103. PhytoHealth Corporation Business Overview
Table 104. PhytoHealth Corporation Musculoskeletal System Disorder Product
Table 105. PhytoHealth Corporation Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 106. PhytoHealth Corporation Recent Development
Table 107. Eisai Co., Ltd Company Details
Table 108. Eisai Co., Ltd Business Overview
Table 109. Eisai Co., Ltd Musculoskeletal System Disorder Product
Table 110. Eisai Co., Ltd Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 111. Eisai Co., Ltd Recent Development
Table 112. Astellas Pharma Inc. Company Details
Table 113. Astellas Pharma Inc. Business Overview
Table 114. Astellas Pharma Inc. Musculoskeletal System Disorder Product
Table 115. Astellas Pharma Inc. Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 116. Astellas Pharma Inc. Recent Development
Table 117. AstraZeneca Company Details
Table 118. AstraZeneca Business Overview
Table 119. AstraZeneca Musculoskeletal System Disorder Product
Table 120. AstraZeneca Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 121. AstraZeneca Recent Development
Table 122. Baxter Company Details
Table 123. Baxter Business Overview
Table 124. Baxter Musculoskeletal System Disorder Product
Table 125. Baxter Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 126. Baxter Recent Development
Table 127. GlaxoSmithKline PLC Company Details
Table 128. GlaxoSmithKline PLC Business Overview
Table 129. GlaxoSmithKline PLC Musculoskeletal System Disorder Product
Table 130. GlaxoSmithKline PLC Revenue in Musculoskeletal System Disorder Business (2016-2021) & (US$ Million)
Table 131. GlaxoSmithKline PLC Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Musculoskeletal System Disorder Market Share by Type: 2020 VS 2027
Figure 2. Rheumatoid Arthritis Features
Figure 3. Osteoarthritis Features
Figure 4. Osteoporosis Features
Figure 5. Others Features
Figure 6. Global Musculoskeletal System Disorder Market Share by Application: 2020 VS 2027
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Academic & Research Institutes Case Studies
Figure 9. Musculoskeletal System Disorder Report Years Considered
Figure 10. Global Musculoskeletal System Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Musculoskeletal System Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Musculoskeletal System Disorder Market Share by Regions: 2020 VS 2027
Figure 13. Global Musculoskeletal System Disorder Market Share by Regions (2022-2027)
Figure 14. Global Musculoskeletal System Disorder Market Share by Players in 2020
Figure 15. Global Top Musculoskeletal System Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal System Disorder as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Musculoskeletal System Disorder Revenue in 2020
Figure 17. Global Musculoskeletal System Disorder Revenue Market Share by Type (2016-2021)
Figure 18. Global Musculoskeletal System Disorder Revenue Market Share by Type (2022-2027)
Figure 19. North America Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Musculoskeletal System Disorder Market Share by Type (2016-2027)
Figure 21. North America Musculoskeletal System Disorder Market Share by Application (2016-2027)
Figure 22. North America Musculoskeletal System Disorder Market Share by Country (2016-2027)
Figure 23. United States Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Musculoskeletal System Disorder Market Share by Type (2016-2027)
Figure 27. Europe Musculoskeletal System Disorder Market Share by Application (2016-2027)
Figure 28. Europe Musculoskeletal System Disorder Market Share by Country (2016-2027)
Figure 29. Germany Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Musculoskeletal System Disorder Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Musculoskeletal System Disorder Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Musculoskeletal System Disorder Market Share by Region (2016-2027)
Figure 39. China Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Musculoskeletal System Disorder Market Share by Type (2016-2027)
Figure 47. Latin America Musculoskeletal System Disorder Market Share by Application (2016-2027)
Figure 48. Latin America Musculoskeletal System Disorder Market Share by Country (2016-2027)
Figure 49. Mexico Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Musculoskeletal System Disorder Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Musculoskeletal System Disorder Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Musculoskeletal System Disorder Market Share by Country (2016-2027)
Figure 55. Turkey Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Musculoskeletal System Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AB Science Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 59. AbGenomics International, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 60. Alder BioPharmaceuticals,Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 61. Amgen Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 62. Lexicon Pharmaceuticals, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 63. LG Chem Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 64. OrthoTrophix, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 65. Tarsa Therapeutics, Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 66. PhytoHealth Corporation Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 67. Eisai Co., Ltd Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 68. Astellas Pharma Inc. Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 70. Baxter Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 71. GlaxoSmithKline PLC Revenue Growth Rate in Musculoskeletal System Disorder Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の排卵障害診断市場規模・現状・予測（2021年-2027年） Some significant driving factors for the growth of the ovulation disorder diagnosis market include increasing genetic and hormonal disorders, rising obesity rates, the increasing prevalence of diabetes around the world. Market Analysis and Insights: Global Ovulation Disorder Diagnosis Market The glo…- 世界の甲状腺障害市場規模・現状・予測（2021年-2027年） Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …
- 世界の関節リウマチ診断装置市場規模・現状・予測（2021年-2027年） Rheumatoid Arthritis Diagnostic Device is equipment for Rheumatoid Arthritis Diagnostic. The rising incidence of rheumatoid arthritis has prompted various healthcare organizations and governments to raise awareness about the condition and its treatment plans and diagnostic procedures. Also, in the m…
- 世界の神経疾患診断市場規模・現状・予測（2021年-2027年） Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders. Market Analysis and Insights: Global Neurological Disorder Diagnostics Market The global Neurological Disorder Diagnostics market size is projected to reach US$ 13800 million by 2027, from US$ 10080 mi…
- 世界のHPV関連疾患市場規模・現状・予測（2021年-2027年） HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby. Market Analysis and Insights: Global HPV Associated Disorder Market The global HPV Associated Disorder market size is projected to reach US$ XX million by 2027, from US…